SPI
17.402,17
PKT
+222,98
PKT
+1,30
%
Werbung
Analysen zu SPI-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 15.11.24 | Nestlé Neutral | UBS AG | |
| 14.11.24 | Swiss Re Hold | Jefferies & Company Inc. | |
| 14.11.24 | Swiss Re Hold | Jefferies & Company Inc. | |
| 14.11.24 | Novartis Buy | UBS AG | |
| 14.11.24 | Swiss Re Overweight | JP Morgan Chase & Co. | |
| 14.11.24 | Givaudan Neutral | UBS AG | |
| 14.11.24 | Swiss Re Sector Perform | RBC Capital Markets | |
| 14.11.24 | Swiss Re Buy | UBS AG | |
| 14.11.24 | Nestlé Hold | Jefferies & Company Inc. | |
| 13.11.24 | Roche Neutral | UBS AG | |
| 12.11.24 | DocMorris Sell | UBS AG | |
| 12.11.24 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
| 11.11.24 | Richemont Sector Perform | RBC Capital Markets | |
| 11.11.24 | Richemont Neutral | Goldman Sachs Group Inc. | |
| 11.11.24 | Zurich Insurance Neutral | Goldman Sachs Group Inc. | |
| 11.11.24 | Richemont Buy | Deutsche Bank AG | |
| 11.11.24 | Swiss Re Buy | UBS AG | |
| 08.11.24 | Richemont Overweight | JP Morgan Chase & Co. | |
| 08.11.24 | Richemont Buy | Jefferies & Company Inc. | |
| 08.11.24 | Zurich Insurance Hold | Deutsche Bank AG | |
| 08.11.24 | Richemont Neutral | Goldman Sachs Group Inc. | |
| 08.11.24 | Richemont Sector Perform | RBC Capital Markets | |
| 08.11.24 | Richemont Buy | UBS AG | |
| 08.11.24 | Swiss Re Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 07.11.24 | Zurich Insurance Hold | Jefferies & Company Inc. | |
| 07.11.24 | Novartis Neutral | JP Morgan Chase & Co. | |
| 07.11.24 | Swiss Re Sector Perform | RBC Capital Markets | |
| 07.11.24 | Zurich Insurance Underweight | JP Morgan Chase & Co. | |
| 07.11.24 | Zurich Insurance Neutral | UBS AG | |
| 07.11.24 | Zurich Insurance Neutral | Goldman Sachs Group Inc. | |
| 07.11.24 | Swiss Re Overweight | JP Morgan Chase & Co. | |
| 04.11.24 | ABB (Asea Brown Boveri) Neutral | Goldman Sachs Group Inc. | |
| 31.10.24 | UBS Hold | Deutsche Bank AG | |
| 31.10.24 | UBS Buy | Goldman Sachs Group Inc. | |
| 31.10.24 | Novartis Neutral | Goldman Sachs Group Inc. | |
| 31.10.24 | UBS Outperform | RBC Capital Markets | |
| 31.10.24 | UBS Overweight | JP Morgan Chase & Co. | |
| 30.10.24 | Roche Neutral | UBS AG | |
| 30.10.24 | Novartis Outperform | Bernstein Research | |
| 30.10.24 | Novartis Hold | Deutsche Bank AG |